BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRCC
4176
DELISTED
Monroe Capital Corp
MRCC
| $1.34M | ﹤0.01% |
148,218
+20,690
| +16% | +$207K |
|
4177
Vermilion Energy
VET
$1.76B
| $1.34M | ﹤0.01% |
+70,091
| New | +$1.46M |
|
|
LJPC
4178
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.33M | ﹤0.01% |
418,216
-8,297
| -2% | -$32.3K |
|
|
AUTL
4179
Autolus Therapeutics
AUTL
$506M
| $1.32M | ﹤0.01% |
467,846
+81,132
| +21% | +$247K |
|
4180
Mustang Bio
MBIO
$4.51M
| $1.32M | ﹤0.01% |
3,018
-4,557
| -60% | -$2.52M |
|
4181
State Street SPDR S&P Dividend ETF
SDY
$23.6B
| $1.32M | ﹤0.01% |
11,102
+2,434
| +28% | +$303K |
|
|
TRHC
4182
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.31M | ﹤0.01% |
511,452
-1,167,770
| -70% | -$4.38M |
|
4183
Alamos Gold
AGI
$11.8B
| $1.31M | ﹤0.01% |
187,018
+13,663
| +8% | +$106K |
|
|
FATH
4184
DELISTED
Fathom Digital Manufacturing Corporation
FATH
| $1.31M | ﹤0.01% |
16,890
+10,873
| +181% | +$1.24M |
|
|
BCLI
4185
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.31M | ﹤0.01% |
31,582
-52
| -0.2% | -$2.34K |
|
|
MAXR
4186
PUT
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $1.3M | ﹤0.01% |
+50,000
| New | +$1.56M |
|
|
CVLY
4187
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $1.3M | ﹤0.01% |
57,869
-1,477
| -2% | -$33.7K |
|
4188
Lipocine
LPCN
$17.1M
| $1.29M | ﹤0.01% |
94,882
+2,841
| +3% | +$44.3K |
|
4189
Smith Micro Software
SMSI
$14.7M
| $1.29M | ﹤0.01% |
13,081
-54,453
| -81% | -$6.33M |
|
4190
Silicon Motion
SIMO
$8.6B
| $1.28M | ﹤0.01% |
15,325
-80,839
| -84% | -$6.81M |
|
4191
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
| $1.28M | ﹤0.01% |
20,026
-531
| -3% | -$37.3K |
|
4192
US Global Investors
GROW
$36.3M
| $1.27M | ﹤0.01% |
288,489
+1,696
| +0.6% | +$8.24K |
|
|
IMA
4193
ImageneBio Inc
IMA
$63M
| $1.27M | ﹤0.01% |
23,979
-100,451
| -81% | -$5.54M |
|
|
PHX
4194
DELISTED
PHX Minerals
PHX
| $1.27M | ﹤0.01% |
419,439
+2,833
| +0.7% | +$9.94K |
|
|
TCFC
4195
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $1.27M | ﹤0.01% |
34,504
+8,973
| +35% | +$340K |
|
4196
iShares MSCI Chile ETF
ECH
$1.02B
| $1.26M | ﹤0.01% |
52,517
-58,759
| -53% | -$1.6M |
|
4197
Palladyne AI Corp Warrants
PDYNW
$240K
| $1.26M | ﹤0.01% |
2,518,409
-81,663
| -3% | -$54.5K |
|
4198
Oxford Square Capital
OXSQ
$160M
| $1.25M | ﹤0.01% |
344,400
+48,109
| +16% | +$191K |
|
|
SLI
4199
Standard Lithium
SLI
$500M
| $1.25M | ﹤0.01% |
295,364
-57,439
| -16% | -$340K |
|
|
CNTB
4200
Connect Biopharma Holdings
CNTB
$130M
| $1.25M | ﹤0.01% |
1,434,960
-801,432
| -36% | -$1.18M |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.